Improved biological efficacy of prasugrel one month after an acute coronary syndrome

Int J Cardiol. 2013 Sep 1;167(5):2329-30. doi: 10.1016/j.ijcard.2012.11.012. Epub 2012 Nov 26.

Authors

Marc Laine, Mouhamadou Nazirou Doddo Siddo, Franck Paganelli, Françoise Dignat-George, Laurent Bonello

PMID: 23194787
DOI: 10.1016/j.ijcard.2012.11.012

No abstract available

Keywords: Bleeding; High on-treatment platelet reactivity; Maintenance therapy; Prasugrel; VASP-index.

Publication types

Letter

MeSH terms

Acute Coronary Syndrome / blood
Acute Coronary Syndrome / diagnosis*
Acute Coronary Syndrome / drug therapy*
Follow-Up Studies
Humans
Piperazines / pharmacology
Piperazines / therapeutic use*
Platelet Activation / drug effects
Platelet Activation / physiology
Platelet Aggregation Inhibitors / pharmacology
Platelet Aggregation Inhibitors / therapeutic use*
Prasugrel Hydrochloride
Prospective Studies
Thiophenes / pharmacology
Thiophenes / therapeutic use*
Time Factors
Treatment Outcome

Substances

Piperazines
Platelet Aggregation Inhibitors
Thiophenes
Prasugrel Hydrochloride